Approval · Notice of Compliance 983 · 2000
TRACRIUM: Notice of Compliance 983
Issued February 9, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 983
- Date
- February 9, 2000
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Intravenous Skeletal Neuromuscular Blocking Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRACRIUM | 00675210 | Cancelled Post Market |
Medicinal ingredients
- ATRACURIUM BESYLATE 10 MG per ML